Moloney Securities Asset Management’s AstraZeneca AZN Stock Holding History

Moloney Securities Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$510K	Buy	3,322 +486	+17%	+$73.6K	0.06%	273
2025 Q2	$396K	Sell	2,836 -67	-2%	-$9.39K	0.05%	308
2025 Q1	$427K	Buy	2,903 +6	+0.2%	+$868	0.06%	279
2024 Q4	$380K	Sell	2,897 -2,252	-44%	-$315K	0.05%	301
2024 Q3	$802K	Sell	5,149 -135	-3%	-$21.8K	0.11%	217
2024 Q2	$824K	Buy	5,284 +663	+14%	+$99.8K	0.12%	197
2024 Q1	$626K	Buy	4,621 +346	+8%	+$45.8K	0.09%	229
2023 Q4	$576K	Buy	+4,275	New	+$556K	0.09%	227
2017 Q4	–	Sell	-3,176	Closed	-$215K	–	273
2017 Q3	$215K	Buy	3,176 +39	+1%	+$2.46K	0.1%	241
2017 Q2	$214K	Sell	3,137 -200	-6%	-$13.1K	0.11%	221
2017 Q1	$208K	Buy	+3,337	New	+$194K	0.11%	215

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Moloney Securities Asset Management's AZN Position: Q3 2025 in Review

Moloney Securities Asset Management increased its AstraZeneca (AZN) stake by 17% in Q3 2025, buying an estimated $73.6K and bringing the position to 3,322 shares worth $510K. The position accounts for 0.06% of the portfolio, ranked #273.

Moloney Securities Asset Management first reported a position in AZN in Q1 2017 and has held it in 11 quarters since. The position peaked at $824K in Q2 2024. 1,287 funds tracked by Wall St. Rank hold AZN as of Q3 2025.

Moloney Securities Asset Management held 3,322 shares of AstraZeneca worth $510K as of Q3 2025.
Moloney Securities Asset Management bought 486 AstraZeneca shares in Q3 2025, an estimated $73.6K.
AstraZeneca made up 0.06% of Moloney Securities Asset Management's portfolio in Q3 2025, its #273 holding.
Moloney Securities Asset Management first reported a position in AstraZeneca in Q1 2017 and has held it in 11 quarters since.
Moloney Securities Asset Management's AstraZeneca position peaked at $824K in Q2 2024.
1,287 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.

Based on Moloney Securities Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.